Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zyrtec ragweed season push

This article was originally published in The Tan Sheet

Executive Summary

Almost half of allergy sufferers who work maintain their symptoms are responsible for reduced productivity on the job, while 46% of people "feel less attractive or sexy because of their allergies," according to a survey sponsored by Zyrtec (certirizine) developer UCB Pharma and U.S. marketer Pfizer. The 500-person survey shows the impact of allergies on personal and professional lives "when not managed effectively," Pfizer and UCB state in an Aug. 24 release; the study was conducted online in April. The firms are reminding consumers Zyrtec is indicated to treat ragweed, which is currently in season...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097237

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel